Increased serum amyloid A and its association with autoantibodies, acute phase reactants and disease activity in patients with rheumatoid arthritis

By  

Molecular Medicine Reports, Vol. 11, Iss. 2, 2015-01 ,pp. : 1528-1534

Spandidos Publications

Access to resources Recommend Favorite

Lack of efficacy of recombinant human interleukin-6 in patients with advanced renal cell cancer: results of a phase II study

By Schuler M.   Bruntsch U.   Spath-Schwalbe E.   Schrezenmeier H.   Peschel C.   Farber L.   Burger K.J.   Leiszner J.   Huber C.   Aulitzky W.E.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 754-756

Elsevier

Access to resources Recommend Favorite

A Phase I study of recombinant human interleukin-21 (rIL-21) in combination with sunitinib in patients with metastatic renal cell carcinoma (RCC)

By Grünwald Viktor   Desar Ingrid M. E.   Haanen John   Fiedler Walter   Mouritzen Ulrik   Olsen M. W. Brændholt   van Herpen Carla M. L.  

Acta Oncologica, Vol. 50, Iss. 1, 2011-01 ,pp. : 121-126

Informa Healthcare

Access to resources Recommend Favorite

Renal Cell Carcinoma and Interleukin-2: A Review

By Wagstaff J.   Baars J.W.   Wolbink G.-J.   Hoekman K.   Eerenberg-Belmer A.J.M.   Hack C.E.  

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 401-408

Elsevier

Access to resources Recommend Favorite

Acute Effects of Pamidronate Administration on Serum Levels of Interleukin-6 in Advanced Solid Tumour Patients with Bone Metastases and their Possible Implications in the Immunotherapy of Cancer with Interleukin-2

By Lissoni P.   Cazzaniga M.   Barni S.   Perego M.S.   Brivio F.   Fumagalli L.   Tancini G.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 304-306

Elsevier

Access to resources Recommend Favorite